MDxHealth SA operates as a molecular diagnostics company in Germany, the Netherlands, Poland, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy.
Read More…
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone324-364-2070
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$28.40 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
MDxHealth (OTCMKTS:MXDHF) Frequently Asked Questions
What is MDxHealth's stock symbol?
MDxHealth trades on the OTCMKTS under the ticker symbol "MXDHF."
What is the consensus analysts' recommendation for MDxHealth?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MDxHealth.
Has MDxHealth been receiving favorable news coverage?
News stories about MXDHF stock have been trending somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. MDxHealth earned a daily sentiment score of -1.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for MDxHealth.
Who are some of MDxHealth's key competitors?
Some companies that are related to MDxHealth include LONMIN PLC/S (LNMIY), Amerisur Resources (ASUXF), Absolute Software (ALSWF), PARKSON RETAIL/ADR (PKSGY), Wandisco (WANSF), Poxel (PXXLF), FOXTONS GRP PLC/ADR (FXTGY), Bank Of Princeton (BPRN), Capstone Mining (CSFFF), NicOx (NICXF), TAIWAN FD INC/SH (TWN), 5N Plus (FPLSF), Paladin Energy (PALAF), Bonterra Energy (BNEFF) and Integra Resrcs (IRRZF).
What other stocks do shareholders of MDxHealth own?
Who are MDxHealth's key executives?
MDxHealth's management team includes the folowing people:
- Mr. Michael K. McGarrity, CEO & Director (Age 56)
- Mr. Kurt Schmidt, Exec. VP of Fin. & Interim CFO (Age 58)
- Dr. Wim Van Criekinge, Chief Scientific Officer (Age 47)
- Mr. Joseph Sollee, Chief Compliance Officer, Exec. VP of Corp. Devel. & Gen. Counsel (Age 54)
- Mr. Jean-Marc Roelandt, CFO & Exec. VP (Leave of Absence) (Age 54)
How do I buy shares of MDxHealth?
Shares of MXDHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is MDxHealth's stock price today?
One share of MXDHF stock can currently be purchased for approximately $1.07.
How big of a company is MDxHealth?
What is MDxHealth's official website?
How can I contact MDxHealth?
MDxHealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 324-364-2070 or via email at [email protected]
MarketBeat Community Rating for MDxHealth (OTCMKTS MXDHF)
MarketBeat's community ratings are surveys of what our community members think about MDxHealth and other stocks. Vote "Outperform" if you believe MXDHF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MXDHF will underperform the S&P 500 over the long term. You may vote once every thirty days.
